Patent US5049165A successfully refreshed from Google Patents.
Patent US5063242A successfully refreshed from Google Patents.
US5063242A
Expired / Lapsed
US
⏱️ 0.0 years remaining
7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents
Assignee: Warner Lambert Co LLC
•
Filing: 1990-07-11
•
Granted: 1991-11-05
•
Expires: 2010-07-11
Abstract
Abstract Methods for using substituted phenoxy-, 1-, and 2-naphthalenyloxy-, indenyl-, indolyl-, benzo[b]-furanyl-, and benzo[b]thienylcarboxamides of 7,8-(substituted-diamino)-1-oxaspiro[4.5]decanes as cerebrovascular, diuretic, and antiinflammatory agents are disclosed. Pharmaceutical compositions employing the compounds are also disclosed.
Inventors
- 👤 David C. Horwell
- 👤 David C. Rees
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 03:15
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61K31/335; A61K31/34; A61K31/38; A61K31/403; A61K31/404; A61K31/405; A61K31/41; A61K31/435; A61K31/44; A61K31/445
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
248 words
A method for treating inflammation which comprises administering to a patient in need of said treatment a therapeutically effective amount of a compound in unit dosage form of formula ##STR13## or a pharmaceutically acceptable salt thereof, wherein n is an integer of from one to six; either of X or Y is oxygen and the other is --CH 2 --; R is selected from ##STR14## where R 4 and R 5 are independently hydrogen, fluorine, chlorine, bromine, nitro, trifluoromethyl, alkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, or aryl; b) 3,4,5-trimethylphenoxy; ##STR15## where R 6 is hydrogen, fluorine, chlorine, alkyl of from one to six carbon atoms, or aryl; Z is --CH 2 --, --O--, --S--, or --NR 7 -- where R 7 is hydrogen, alkanoyl of from one to six carbon atoms, or alkyl of from one to six carbon atoms; ##STR16## wherein R 8 and R 9 are independently hydrogen, fluorine, bromine, alkyl of from one to six carbon atoms, or alkoxy of from one to four carbon atoms; or ##STR17## where R 8 and R 9 are as defined above; where R 2 is methyl and R 3 is hydrogen, alkyl of from one to six carbon atoms, ##STR18## where R 10 is alkyl of from one to four carbon atoms; or where R 2 and R 3 when taken together with the nitrogen atom to which they are attached, form a pyrrolidinyl, piperidinyl, or hexahydro-1H-azepinyl ring.
Claim 2
Independent Claim
248 words
A method for treating inflammation which comprises administering to a patient in need of said treatment a therapeutically effective amount of a compound in unit dosage form of formula ##STR13## or a pharmaceutically acceptable salt thereof, wherein n is an integer of from one to six; either of X or Y is oxygen and the other is --CH 2 --; R is selected from ##STR14## where R 4 and R 5 are independently hydrogen, fluorine, chlorine, bromine, nitro, trifluoromethyl, alkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, or aryl; b) 3,4,5-trimethylphenoxy; ##STR15## where R 6 is hydrogen, fluorine, chlorine, alkyl of from one to six carbon atoms, or aryl; Z is --CH 2 --, --O--, --S--, or --NR 7 -- where R 7 is hydrogen, alkanoyl of from one to six carbon atoms, or alkyl of from one to six carbon atoms; ##STR16## wherein R 8 and R 9 are independently hydrogen, fluorine, bromine, alkyl of from one to six carbon atoms, or alkoxy of from one to four carbon atoms; or ##STR17## where R 8 and R 9 are as defined above; where R 2 is methyl and R 3 is hydrogen, alkyl of from one to six carbon atoms, ##STR18## where R 10 is alkyl of from one to four carbon atoms; or where R 2 and R 3 when taken together with the nitrogen atom to which they are attached, form a pyrrolidinyl, piperidinyl, or hexahydro-1H-azepinyl ring.
Claim 3
Dependent Claim
11 words
A method according to claim 1 wherein the compound is (-)-(5α,7α,8β)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-4benzo[b]furanacetamide.
Claim 4
Dependent Claim
26 words
A method according to claim 1 wherein 0.001 mg to 1 mg/kg of weight per day of the compound or the pharmaceutically acceptable salt is administered.
References Cited (Backward Citations)
US4499286A
Cited
US4598087A
Cited
US4737493A
Cited
US4663343A
Cited
EP0254545B1
Cited
EP0258095A1
Cited
EP0258096A2
Cited
EP0260041A1
Cited
EP0260555A1
Cited
EP0261842A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-11-04 | 1995-05-06 | 1995-11-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-11-04 | 1999-05-06 | 1999-11-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-11-04 | 2003-05-06 | 2003-11-05 | $7700.00 | Window Closed / Lapsed |